Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 8c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.70), $0.08 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid